Efficacy and Safety Study of Lurbinectedin and Dostarlimab in Cancer Patients: Protocol VHIO21001 - LiDer
Clinical trial NCT06385548 · WITHDRAWN
Trial details
- NCT number
- NCT06385548
- Sponsor
- Vall d'Hebron Institute of Oncology
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2024-05-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.